| 1 |
32237281 | Are cytochrome P4502D6 and apolipoprotein E genotypes associated with long-term cognitive and functional changes in patients treated with donepezil? | 2020 Sep |
3 |
| 2 |
33251785 | Biophysical, Biochemical, and Behavioral Implications of ApoE3 Conjugated Donepezil Nanomedicine in a Aβ1-42 Induced Alzheimer's Disease Rat Model. | 2020 Dec 16 |
3 |
| 3 |
33383743 | ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood-Brain Barrier. | 2020 Dec 29 |
1 |
| 4 |
31418556 | Design and Biological Evaluation of Lipoprotein-Based Donepezil Nanocarrier for Enhanced Brain Uptake through Oral Delivery. | 2019 Sep 18 |
3 |
| 5 |
31564952 | Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer's disease and vascular dementia. | 2019 |
2 |
| 6 |
29605487 | Association between ABCA1 gene polymorphisms and the therapeutic response to donepezil therapy in Han Chinese patients with Alzheimer's disease. | 2018 Jun |
1 |
| 7 |
30349215 | Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients. | 2018 |
1 |
| 8 |
27716659 | Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms. | 2017 |
2 |
| 9 |
27911294 | Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment. | 2017 |
1 |
| 10 |
26768225 | The roles of apolipoprotein E3 and CYP2D6 (rs1065852) gene polymorphisms in the predictability of responses to individualized therapy with donepezil in Han Chinese patients with Alzheimer's disease. | 2016 Feb 12 |
5 |
| 11 |
27207906 | Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases. | 2016 Jun |
2 |
| 12 |
27282366 | Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis. | 2016 Oct |
3 |
| 13 |
27567841 | Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects. | 2016 Oct 4 |
5 |
| 14 |
26402762 | APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease. | 2015 |
2 |
| 15 |
25538729 | Influence of the rs1080985 Single Nucleotide Polymorphism of the CYP2D6 Gene and APOE Polymorphism on the Response to Donepezil Treatment in Patients with Alzheimer's Disease in China. | 2014 Sep |
3 |
| 16 |
25796815 | [ApoE gene polymorphism as a predictor of therapeutic response to treatment acetylcholinesterase inhibitor for elderly patients with Alzheimer's and vascular dementia types]. | 2014 |
5 |
| 17 |
22986607 | Effect of CYP2D6*10 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer's disease. | 2013 Mar |
2 |
| 18 |
23609381 | Concentration of donepezil to the cognitive response in Alzheimer disease. | 2013 Jun |
1 |
| 19 |
23950644 | Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with alzheimer's disease. | 2013 |
2 |
| 20 |
20102379 | Changes in cognitive functions of patients with dementia of the Alzheimer type following long-term administration of donepezil hydrochloride: relating to changes attributable to differences in apolipoprotein E phenotype. | 2010 Jan |
1 |
| 21 |
19738170 | Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease. | 2009 Sep 8 |
1 |
| 22 |
17452062 | Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. | 2008 Sep |
1 |
| 23 |
18401173 | Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease. | 2008 |
3 |
| 24 |
19595949 | Mild cognitive impairment and cognitive impairment, no dementia: Part B, therapy. | 2007 Oct |
1 |
| 25 |
15829527 | Vitamin E and donepezil for the treatment of mild cognitive impairment. | 2005 Jun 9 |
1 |
| 26 |
16103669 | Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease. | 2005 |
2 |
| 27 |
22034396 | Pharmacotherapy of mild cognitive impairment. | 2004 Dec |
2 |
| 28 |
12007670 | ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model. | 2002 Jun |
2 |
| 29 |
12142731 | Presence or absence of at least one epsilon 4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer's disease. | 2002 Jul |
2 |